Page last updated: 2024-12-05

syringic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Syringic acid is a phenolic compound found in various plants, particularly in the lignocellulosic biomass of hardwood trees. It is known for its antioxidant properties and has been studied for its potential applications in various fields, including medicine, cosmetics, and food preservation. Syringic acid can be synthesized from lignin, a complex polymer present in plant cell walls. One common method involves the alkaline hydrolysis of lignin followed by purification. Syringic acid exhibits a wide range of biological activities, including anti-inflammatory, antimicrobial, and anticancer effects. Its antioxidant properties are attributed to its ability to scavenge free radicals, which are highly reactive molecules that can damage cells. Research on syringic acid focuses on exploring its therapeutic potential, particularly in treating inflammatory diseases, infections, and cancer. Its role in plant growth and defense mechanisms is also being investigated. The increasing interest in syringic acid is driven by its natural origin, its diverse biological activities, and its potential for sustainable applications in various industries.'

syringic acid: RN given refers to parent cpd; structure in third source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

syringic acid : A dimethoxybenzene that is 3,5-dimethyl ether derivative of gallic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10742
CHEMBL ID1414
CHEBI ID68329
SCHEMBL ID42751
MeSH IDM0042355

Synonyms (71)

Synonym
BRD-K51980294-001-01-9
nsc-2129
3,5-dimethoxy-4-hydroxybenzoic acid
4-hydroxy-3,5-dimethoxybenzoic acid
nsc2129
benzoic acid, 4-hydroxy-3,5-dimethoxy-
KBIO1_001525
DIVK1C_006581
brn 2115262
3,5-dimethoxy-4-hydroxybenzyl acid
einecs 208-486-8
cedar acid
nsc 2129
ai3-24376
gallic acid 3,5-dimethyl ether
syringic acid
530-57-4
inchi=1/c9h10o5/c1-13-6-3-5(9(11)12)4-7(14-2)8(6)10/h3-4,10h,1-2h3,(h,11,12
syringic acid, >=95%
KBIO3_002814
SPECPLUS_000485
SPECTRUM3_001866
BSPBIO_003312
SPECTRUM5_000963
NCGC00178148-01
bdbm50187132
chebi:68329 ,
CHEMBL1414 ,
AKOS000269664
BMSE000607
BMSE010206
G0014
BBL012974
STL163855
S3629
unii-e390o181h5
4-10-00-01995 (beilstein handbook reference)
e390o181h5 ,
FT-0632317
2,6-dimethoxy-4-carboxyphenol
syringic acid [inci]
CCG-214218
SCHEMBL42751
SY005479
mfcd00002552
DTXSID0060191 ,
Q-100604
PS-8244
3,5-dimethyl ether gallic acid
syra
3,5-dimethoxy-4-hydroxy benzoic acid
AC-7975
syringic acid, analytical standard
3,5-dimethoxy-4-hydroxybenzoate
3,5-dimethyl-4-hydroxybenzoate
F3157-0001
Q408428
HY-N0339
CS-0008899
syringlicacid
A14823
EN300-117146
HMS3885G17
4-hydroxy-3,5-dimethoxybenzoicacid
3,5-dimethoxy-4-hydroxybenzoicacid
3 pound not5-dimethoxy-4-hydroxybenzoicacid
dtxcid2041337
3,5-dimethoxy-4-hydroxybenzoic acid, 4-hydroxy-3,5-dimethoxy-benzoic acid
Z1255360342
3,5-dimethoxy-4-oxidanyl-benzoic acid
IJP ,

Research Excerpts

Overview

Syringic acid (SA) is a natural phenolic compound that is found in medicinal herbs and dietary plants. SA is an active carcinogenesis inhibitor; however, the low bioavailability and unstable functional groups hinder its activity.

ExcerptReferenceRelevance
"Syringic acid (SA) is a phenolic compound present in the fruit of the assai palm, Euterpe oleracea, and in the mycelium of the shiitake mushroom, Lentinula edodes."( Dietary syringic acid reduces fat mass in an ovariectomy-induced mouse model of obesity.
Homma, Y; Iwamoto, K; Kawaguchi, N; Moriyama, T; Shirasaka, N; Suzuki, T; Tanaka, T; Wada, M; Yano, E, 2021
)
1.78
"Syringic acid (SA) is a natural phenolic compound that is found in medicinal herbs and dietary plants."( The role of syringic acid as a neuroprotective agent for neurodegenerative disorders and future expectations.
Armagan, K; Gül, Z; Ogut, E, 2022
)
1.82
"Syringic acid (SA) is an active carcinogenesis inhibitor; however, the low bioavailability and unstable functional groups hinder its activity. "( In vitro and in silico perspectives to explain anticancer activity of a novel syringic acid analog ((4-(1H-1, 3-benzodiazol-2-yl)-2, 6-dimethoxy phenol)) through apoptosis activation and NFkB inhibition in K562 leukemia cells.
Cheemanapalli, S; Iyyappan, Y; Kanagaraj, S; Mahesh, Y; Palaniappan, C; Yarrappagaari, S, 2023
)
2.58
"Syringic acid (SA) is a natural phenolic acid that possesses antioxidant properties. "( Syringic acid Attenuates Oxidative Stress in Plasma and Peripheral Blood Mononuclear Cells of Patients with Acute Myeloid Leukemia.
Ansarihadipour, H; Haddadi, N; Mirzania, M, 2023
)
3.8
"Syringic acid (SA) is a polyphenolic compound with anti-inflammatory, anti-apoptotic, antioxidant, and neuromodulator activity."( Syringic acid alleviates valproic acid induced autism via activation of p38 mitogen-activated protein kinase: Possible molecular approach.
Mallan, S; Singh, S, 2023
)
3.07
"Syringic acid (SA) is a natural product with neuroprotective activity in vivo, but the role of SA on Schwann cells remains unclear."( Syringic acid promotes proliferation and migration of Schwann cells via down-regulating miR-451-5p.
Jiang, X; Lin, H; Lin, Y; Yin, G, 2019
)
2.68
"Syringic acid, which is a typical methoxyphenol emitted from wood combustion, can provide heterogeneous reaction sites for gaseous active components, influencing the concentrations of trace gases and the compositions of syringic acid. "( Heterogeneous reaction of ozone with syringic acid: Uptake of O
Han, C; Xue, X; Yang, H; Yang, W; Zhang, T, 2020
)
2.27
"Syringic acid (Syr) is an abundant component in aerosol particles. "( Kinetics and mechanism of syringic acid degradation initiated by hydroxyl radical and sulphate radical in the aqueous phase.
Tong, X; Wang, L; Wang, S, 2020
)
2.3
"Syringic acid is an abundant phenolic acid compound that possesses anti-oxidant, anti-microbial, anti-inflammatory, and anti-endotoxic properties. "( Syringic acid mitigates myocardial ischemia reperfusion injury by activating the PI3K/Akt/GSK-3β signaling pathway.
Chen, J; Hu, Q; Liu, G; Liu, XP; Zhang, BF, 2020
)
3.44
"Syringic acid (SA) is a polyphenolic compound which has antioxidant and anti-inflammatory properties."( Protective mechanism of Syringic acid in an experimental model of Parkinson's disease.
Afşar, E; Ağar, A; Aslan, M; Bülbül, M; Güzelad, Ö; Öğüt, E; Özkan, A; Parlak, H; Sinen, O; Yıldırım, FB, 2021
)
1.65
"Syringic acid (SA) is a phenolic compound present in the fruit of the açaí palm Euterpe oleracea and the mycelium of the shiitake mushroom Lentinula edodes."( Antiosteoporotic activity of a syringic acid diet in ovariectomized mice.
Fukuta, Y; Kawaguchi, N; Moriyama, T; Shirasaka, N; Tanaka, T; Zaima, N, 2017
)
1.46
"Syringic acid (SA) is a natural phenolic compound abundantly available in edible fruits and plants."( Acceleration of wound healing activity with syringic acid in streptozotocin induced diabetic rats.
Chen, J; Ma, S; Ren, J; Xu, F; Yang, M, 2019
)
1.5
"Syringic acid is a probable dominant allelochemical of Rehmannia glutinosa."( [Correlation of Allelopathy of Rehmannia glutinosa Root Exudates and Their Phenolic Acids Contents].
Feng, FJ; Gu, L; Li, XZ; Zhang, B; Zhang, JY; Zhang, LJ; Zhang, ZY, 2015
)
1.14

Effects

Syringic acid (SA) has been reported to exhibit antibacterial ability against various microorganisms. Little work has been done on its effect on Cronobacter sakazakii.

ExcerptReferenceRelevance
"Syringic acid (SA) has been studied for its hepatoprotective, anti-inflammatory, immunomodulatory, free radical scavenging, and antioxidant activities."( Syringic acid triggers reactive oxygen species-mediated cytotoxicity in HepG2 cells.
Ezhilarasan, D; Gheena, S, 2019
)
2.68
"Syringic acid (SA) has been reported to exhibit antibacterial ability against various microorganisms, but little work has been done on its effect on Cronobacter sakazakii. "( Antimicrobial activity of syringic acid against Cronobacter sakazakii and its effect on cell membrane.
Chen, Y; Dong, R; Jia, Z; Liu, X; Shi, C; Song, K; Sun, Y; Xia, X; Yang, M; Zhang, X; Zheng, Z, 2016
)
2.18

Treatment

ExcerptReferenceRelevance
"Syringic acid treatment resulted in a significant dose-dependent inhibition of cellular proliferation, induction of apoptosis through increasing cellular ROS and DNA damage levels, as well as downregulating major proliferative genes."( In vitro and in vivo anticancer effects of syringic acid on colorectal cancer: Possible mechanistic view.
Darband, SG; Kaviani, M; Majidinia, M; Mihanfar, A; Mirza-Aghazadeh-Attari, M; Sadighparvar, S; Yousefi, B, 2021
)
1.61

Pharmacokinetics

ExcerptReferenceRelevance
" So the pharmacokinetic parameters were calculated out."( [Study on the pharmacokinetics and bioavailability of syringic acid in rabbits].
Guo, X; Liu, Y; Lü, Z; Xie, W, 2003
)
0.57

Compound-Compound Interactions

Gigantol combined with syringic acid shows good anti-cataract, their action mechanism is reflected in their good collaborative inhibitory effect on AR.

ExcerptReferenceRelevance
"To study the anti-cataract effect of gigantol combined with syringic acid and their action mechanism."( [Study on anti-cataract effect of gigantol combined with syringic acid and their mechanism].
Diao, H; Fang, H; Gao, X; Gu, L; Gu, Q; Qi, H; Wang, L; Wang, Z; Wei, X; Yi, Y, 2012
)
0.87
"H202-induced lens oxidative injury in vitro rat model was establish to observe the impact of gigantol combined with syringic acid on lens transparency under a dissecting microscope."( [Study on anti-cataract effect of gigantol combined with syringic acid and their mechanism].
Diao, H; Fang, H; Gao, X; Gu, L; Gu, Q; Qi, H; Wang, L; Wang, Z; Wei, X; Yi, Y, 2012
)
0.83
"Gigantol combined with syringic acid shows good anti-cataract, their action mechanism is reflected in their good collaborative inhibitory effect on AR."( [Study on anti-cataract effect of gigantol combined with syringic acid and their mechanism].
Diao, H; Fang, H; Gao, X; Gu, L; Gu, Q; Qi, H; Wang, L; Wang, Z; Wei, X; Yi, Y, 2012
)
0.93

Bioavailability

Syringic acid (SA) is an active carcinogenesis inhibitor. Low bioavailability and unstable functional groups hinder its activity. TPGS liposome was successfully prepared to improve oral bioavailability of SA.

ExcerptReferenceRelevance
"To study the pharmacokinetics and bioavailability of syringic acid(SA) in rabbits by HPLC."( [Study on the pharmacokinetics and bioavailability of syringic acid in rabbits].
Guo, X; Liu, Y; Lü, Z; Xie, W, 2003
)
0.82
" By comparing the AUC of the two curves, bioavailability was obtained."( [Study on the pharmacokinetics and bioavailability of syringic acid in rabbits].
Guo, X; Liu, Y; Lü, Z; Xie, W, 2003
)
0.57
" fitted in a two-compartment open model and the absolute bioavailability was 86."( [Study on the pharmacokinetics and bioavailability of syringic acid in rabbits].
Guo, X; Liu, Y; Lü, Z; Xie, W, 2003
)
0.57
" The protective effects of SA are mediated by reducing oxidative stress and retaining the bioavailability of NO in the cardiovascular system."( Syringic acid ameliorates (L)-NAME-induced hypertension by reducing oxidative stress.
Kumar, S; Prahalathan, P; Raja, B, 2012
)
1.82
" Results from permeability studies evidenced that SYA did not impact Imatinib's permeability across membranes while suggesting improved bioavailability through higher kinetic solubility at the biological barriers."( Bioinspired co-crystals of Imatinib providing enhanced kinetic solubility.
Dix, I; Galli, B; Gutmann, M; Harlacher, C; Holzgrabe, U; Meinel, L; Müller-Buschbaum, K; Piechon, P; Reggane, M; Saedtler, M; Wiest, J; Zottnick, SH, 2018
)
0.48
"In this study, syringic acid-loaded TPGS liposome (SA-TPGS-Ls) was successfully prepared to improve oral bioavailability of syringic acid (SA)."( Preparation and Characterization of Syringic Acid-Loaded TPGS Liposome with Enhanced Oral Bioavailability and In Vivo Antioxidant Efficiency.
Adu-Frimpong, M; Li, W; Liu, Y; Sun, C; Wang, Q; Xu, X; Yu, J, 2019
)
1.14
" Nevertheless, low solubility and bioavailability hamper the application of SA."( Development of TPGS/F127/F68 mixed polymeric micelles: Enhanced oral bioavailability and hepatoprotection of syringic acid against carbon tetrachloride-induced hepatotoxicity.
Adu-Frimpong, M; Deng, W; Li, W; Li, Y; Ma, P; Sun, C; Xu, X; Yu, J; Zhang, H; Zhu, Y, 2020
)
0.77
"Syringic acid (SA) is an active carcinogenesis inhibitor; however, the low bioavailability and unstable functional groups hinder its activity."( In vitro and in silico perspectives to explain anticancer activity of a novel syringic acid analog ((4-(1H-1, 3-benzodiazol-2-yl)-2, 6-dimethoxy phenol)) through apoptosis activation and NFkB inhibition in K562 leukemia cells.
Cheemanapalli, S; Iyyappan, Y; Kanagaraj, S; Mahesh, Y; Palaniappan, C; Yarrappagaari, S, 2023
)
2.58
" However, their poor bioavailability restricts their functional activities in vivo, which is a challenging issue in the application of blueberry anthocyanins."( Effects of α-casein on the excretion of blueberry anthocyanins via urine and feces: Analysis of their bioavailability.
Bao, Y; Jin, Z; Lang, Y; Li, B; Meng, X; Shen, Y; Tian, J; Yang, S; Yang, Y; Zang, Z, 2023
)
0.91

Dosage Studied

ExcerptRelevanceReference
" niveum were stimulated at lower concentrations of syringic acid, though inhibited by higher dosage compared with control."( In vitro physiological responses of Fusarium oxysporum f. sp. niveum to exogenously applied syringic acid.
Cao, Y; Chen, AQ; Chen, G; Huang, QW; Liu, YX; Luo, J; Mao, ZS; Shen, QR; Tang, Z; Wu, HS,
)
0.6
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
benzoic acidsAny aromatic carboxylic acid that consists of benzene in which at least a single hydrogen has been substituted by a carboxy group.
dimethoxybenzeneAny methoxybenzene that consists of a benzene skeleton substituted with two methoxy groups and its derivatives.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (21)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)100.00000.03403.987110.0000AID1059453
Carbonic anhydrase 12Homo sapiens (human)Ki9.01000.00021.10439.9000AID462279
Carbonic anhydrase 1Homo sapiens (human)Ki539.38330.00001.372610.0000AID1799599; AID462270
Carbonic anhydrase 2Homo sapiens (human)Ki539.06330.00000.72369.9200AID1799599; AID462271
Carbonic anhydrase 3Homo sapiens (human)Ki8.58000.00022.010210.0000AID462272
72 kDa type IV collagenaseHomo sapiens (human)IC50 (µMol)200.00000.00001.284810.0000AID1799773
MatrilysinHomo sapiens (human)IC50 (µMol)200.00000.00142.085910.0000AID1799773
Pyruvate kinase PKMHomo sapiens (human)IC50 (µMol)13.80000.50002.788610.0000AID1881860
Carbonic anhydrase 4Homo sapiens (human)Ki10.60000.00021.97209.9200AID462273
Carbonic anhydrase 6Homo sapiens (human)Ki7.55000.00011.47109.9200AID462276
Adenosine receptor A1Rattus norvegicus (Norway rat)Ki17.85000.00011.20929.9700AID462275; AID462279; AID462281
Adenosine receptor A2aRattus norvegicus (Norway rat)Ki8.47500.00021.494010.0000AID462277; AID462281
Carbonic anhydrase 5A, mitochondrialHomo sapiens (human)Ki6.34000.00001.27259.9000AID462274
Carbonic anhydrase 7Homo sapiens (human)Ki7.81000.00021.37379.9000AID462277
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)IC50 (µMol)200.00000.06003.89568.3000AID1799773
Alpha-(1,3)-fucosyltransferase 7Homo sapiens (human)IC50 (µMol)200.00000.06003.89568.3000AID1799773
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)IC50 (µMol)200.00000.06003.89568.3000AID1799773
Carbonic anhydrase 9Homo sapiens (human)Ki8.20000.00010.78749.9000AID462278
Carbonic anhydrase 13Mus musculus (house mouse)Ki11.00000.00021.39749.9000AID462280
Carbonic anhydrase 14Homo sapiens (human)Ki9.14000.00021.50999.9000AID462281
Carbonic anhydrase 5B, mitochondrialHomo sapiens (human)Ki35.40000.00001.34129.9700AID462275
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (114)

Processvia Protein(s)Taxonomy
estrous cycleCarbonic anhydrase 12Homo sapiens (human)
chloride ion homeostasisCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
response to bacteriumCarbonic anhydrase 3Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 3Homo sapiens (human)
angiogenesis72 kDa type IV collagenaseHomo sapiens (human)
ovarian follicle development72 kDa type IV collagenaseHomo sapiens (human)
ovulation from ovarian follicle72 kDa type IV collagenaseHomo sapiens (human)
luteinization72 kDa type IV collagenaseHomo sapiens (human)
blood vessel maturation72 kDa type IV collagenaseHomo sapiens (human)
intramembranous ossification72 kDa type IV collagenaseHomo sapiens (human)
proteolysis72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of cell adhesion72 kDa type IV collagenaseHomo sapiens (human)
heart development72 kDa type IV collagenaseHomo sapiens (human)
embryo implantation72 kDa type IV collagenaseHomo sapiens (human)
parturition72 kDa type IV collagenaseHomo sapiens (human)
response to xenobiotic stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to mechanical stimulus72 kDa type IV collagenaseHomo sapiens (human)
peripheral nervous system axon regeneration72 kDa type IV collagenaseHomo sapiens (human)
response to activity72 kDa type IV collagenaseHomo sapiens (human)
protein metabolic process72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix disassembly72 kDa type IV collagenaseHomo sapiens (human)
protein catabolic process72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of cell migration72 kDa type IV collagenaseHomo sapiens (human)
collagen catabolic process72 kDa type IV collagenaseHomo sapiens (human)
response to retinoic acid72 kDa type IV collagenaseHomo sapiens (human)
cellular response to reactive oxygen species72 kDa type IV collagenaseHomo sapiens (human)
response to nicotine72 kDa type IV collagenaseHomo sapiens (human)
endodermal cell differentiation72 kDa type IV collagenaseHomo sapiens (human)
response to hydrogen peroxide72 kDa type IV collagenaseHomo sapiens (human)
response to estrogen72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of vasoconstriction72 kDa type IV collagenaseHomo sapiens (human)
ephrin receptor signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
macrophage chemotaxis72 kDa type IV collagenaseHomo sapiens (human)
response to electrical stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to hyperoxia72 kDa type IV collagenaseHomo sapiens (human)
face morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
bone trabecula formation72 kDa type IV collagenaseHomo sapiens (human)
prostate gland epithelium morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
cellular response to amino acid stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to interleukin-172 kDa type IV collagenaseHomo sapiens (human)
cellular response to estradiol stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to UV-A72 kDa type IV collagenaseHomo sapiens (human)
cellular response to fluid shear stress72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
response to amyloid-beta72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix organization72 kDa type IV collagenaseHomo sapiens (human)
response to hypoxia72 kDa type IV collagenaseHomo sapiens (human)
tissue remodeling72 kDa type IV collagenaseHomo sapiens (human)
membrane protein ectodomain proteolysisMatrilysinHomo sapiens (human)
membrane protein intracellular domain proteolysisMatrilysinHomo sapiens (human)
antibacterial peptide secretionMatrilysinHomo sapiens (human)
antibacterial peptide biosynthetic processMatrilysinHomo sapiens (human)
proteolysisMatrilysinHomo sapiens (human)
response to xenobiotic stimulusMatrilysinHomo sapiens (human)
extracellular matrix disassemblyMatrilysinHomo sapiens (human)
positive regulation of cell migrationMatrilysinHomo sapiens (human)
collagen catabolic processMatrilysinHomo sapiens (human)
regulation of cell population proliferationMatrilysinHomo sapiens (human)
defense response to Gram-negative bacteriumMatrilysinHomo sapiens (human)
defense response to Gram-positive bacteriumMatrilysinHomo sapiens (human)
extracellular matrix organizationMatrilysinHomo sapiens (human)
programmed cell deathPyruvate kinase PKMHomo sapiens (human)
canonical glycolysisPyruvate kinase PKMHomo sapiens (human)
positive regulation of sprouting angiogenesisPyruvate kinase PKMHomo sapiens (human)
positive regulation of cytoplasmic translationPyruvate kinase PKMHomo sapiens (human)
glycolytic processPyruvate kinase PKMHomo sapiens (human)
cellular response to insulin stimulusPyruvate kinase PKMHomo sapiens (human)
bicarbonate transportCarbonic anhydrase 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 4Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of bitter tasteCarbonic anhydrase 6Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 6Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 7Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 7Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 7Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 7Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 7Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 7Homo sapiens (human)
protein glycosylation4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
protein N-linked glycosylation4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
protein O-linked glycosylation4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
ceramide metabolic process4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
glycosphingolipid biosynthetic process4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
oligosaccharide biosynthetic process4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
N-glycan fucosylation4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
L-fucose catabolic process4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
oocyte axis specification4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
regulation of type IV hypersensitivityAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
leukocyte migration involved in immune responseAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
leukocyte migration involved in inflammatory responseAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
protein glycosylationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
ceramide metabolic processAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
inflammatory responseAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
embryo implantationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
oligosaccharide biosynthetic processAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
regulation of cell-cell adhesionAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
positive regulation of cell-cell adhesionAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
L-fucose catabolic processAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
positive regulation of cell adhesionAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
regulation of insulin receptor signaling pathwayAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
regulation of cell adhesion molecule productionAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
T cell migrationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
lymphocyte migration into lymph nodeAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
positive regulation of neutrophil migrationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
regulation of leukocyte cell-cell adhesionAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
regulation of leukocyte tethering or rollingAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
positive regulation of leukocyte tethering or rollingAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
positive regulation of leukocyte adhesion to vascular endothelial cellAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
regulation of neutrophil extravasationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
fucosylationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
memory B cell differentiationCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
N-acetylneuraminate metabolic processCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
protein N-linked glycosylationCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
ganglioside biosynthetic process via lactosylceramideCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
O-glycan processingCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
keratan sulfate biosynthetic processCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
viral protein processingCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
protein modification processCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
sialylationCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
negative regulation of activated CD8-positive, alpha-beta T cell apoptotic processCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
protein sialylationCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
protein glycosylationCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 14Homo sapiens (human)
response to bacteriumCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (29)

Processvia Protein(s)Taxonomy
zinc ion bindingCarbonic anhydrase 12Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 12Homo sapiens (human)
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 3Homo sapiens (human)
protein bindingCarbonic anhydrase 3Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 3Homo sapiens (human)
nickel cation bindingCarbonic anhydrase 3Homo sapiens (human)
fibronectin binding72 kDa type IV collagenaseHomo sapiens (human)
endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
metalloendopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
serine-type endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
protein binding72 kDa type IV collagenaseHomo sapiens (human)
metallopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
zinc ion binding72 kDa type IV collagenaseHomo sapiens (human)
endopeptidase activityMatrilysinHomo sapiens (human)
metalloendopeptidase activityMatrilysinHomo sapiens (human)
serine-type endopeptidase activityMatrilysinHomo sapiens (human)
protein bindingMatrilysinHomo sapiens (human)
metallopeptidase activityMatrilysinHomo sapiens (human)
zinc ion bindingMatrilysinHomo sapiens (human)
magnesium ion bindingPyruvate kinase PKMHomo sapiens (human)
RNA bindingPyruvate kinase PKMHomo sapiens (human)
mRNA bindingPyruvate kinase PKMHomo sapiens (human)
protein tyrosine kinase activityPyruvate kinase PKMHomo sapiens (human)
pyruvate kinase activityPyruvate kinase PKMHomo sapiens (human)
protein bindingPyruvate kinase PKMHomo sapiens (human)
ATP bindingPyruvate kinase PKMHomo sapiens (human)
MHC class II protein complex bindingPyruvate kinase PKMHomo sapiens (human)
potassium ion bindingPyruvate kinase PKMHomo sapiens (human)
cadherin bindingPyruvate kinase PKMHomo sapiens (human)
protein bindingCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 4Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 6Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 6Homo sapiens (human)
G protein-coupled adenosine receptor activityAdenosine receptor A2aRattus norvegicus (Norway rat)
carbonate dehydratase activityCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 7Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 7Homo sapiens (human)
fucosyltransferase activity4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
alpha-(1->3)-fucosyltransferase activity4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
protein bindingAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
fucosyltransferase activityAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activityAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
alpha-(1->3)-fucosyltransferase activityAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
beta-galactoside (CMP) alpha-2,3-sialyltransferase activityCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
sialyltransferase activityCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferaseCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 14Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 14Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
zinc ion bindingCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (40)

Processvia Protein(s)Taxonomy
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
membraneCarbonic anhydrase 12Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 12Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 12Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 3Homo sapiens (human)
cytosolCarbonic anhydrase 3Homo sapiens (human)
cytoplasmCarbonic anhydrase 3Homo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular region72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
nucleus72 kDa type IV collagenaseHomo sapiens (human)
mitochondrion72 kDa type IV collagenaseHomo sapiens (human)
plasma membrane72 kDa type IV collagenaseHomo sapiens (human)
sarcomere72 kDa type IV collagenaseHomo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
extracellular regionMatrilysinHomo sapiens (human)
extracellular matrixMatrilysinHomo sapiens (human)
extracellular exosomeMatrilysinHomo sapiens (human)
extracellular spaceMatrilysinHomo sapiens (human)
extracellular regionPyruvate kinase PKMHomo sapiens (human)
nucleusPyruvate kinase PKMHomo sapiens (human)
cytoplasmPyruvate kinase PKMHomo sapiens (human)
mitochondrionPyruvate kinase PKMHomo sapiens (human)
rough endoplasmic reticulumPyruvate kinase PKMHomo sapiens (human)
cytosolPyruvate kinase PKMHomo sapiens (human)
ciliumPyruvate kinase PKMHomo sapiens (human)
vesiclePyruvate kinase PKMHomo sapiens (human)
secretory granule lumenPyruvate kinase PKMHomo sapiens (human)
collagen-containing extracellular matrixPyruvate kinase PKMHomo sapiens (human)
extracellular exosomePyruvate kinase PKMHomo sapiens (human)
extracellular vesiclePyruvate kinase PKMHomo sapiens (human)
ficolin-1-rich granule lumenPyruvate kinase PKMHomo sapiens (human)
cytoplasmPyruvate kinase PKMHomo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 4Homo sapiens (human)
rough endoplasmic reticulumCarbonic anhydrase 4Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentCarbonic anhydrase 4Homo sapiens (human)
Golgi apparatusCarbonic anhydrase 4Homo sapiens (human)
trans-Golgi networkCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
external side of plasma membraneCarbonic anhydrase 4Homo sapiens (human)
cell surfaceCarbonic anhydrase 4Homo sapiens (human)
membraneCarbonic anhydrase 4Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 4Homo sapiens (human)
transport vesicle membraneCarbonic anhydrase 4Homo sapiens (human)
secretory granule membraneCarbonic anhydrase 4Homo sapiens (human)
brush border membraneCarbonic anhydrase 4Homo sapiens (human)
perinuclear region of cytoplasmCarbonic anhydrase 4Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
extracellular regionCarbonic anhydrase 6Homo sapiens (human)
extracellular spaceCarbonic anhydrase 6Homo sapiens (human)
cytosolCarbonic anhydrase 6Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 6Homo sapiens (human)
extracellular spaceCarbonic anhydrase 6Homo sapiens (human)
Golgi membraneAdenosine receptor A2aRattus norvegicus (Norway rat)
mitochondrial matrixCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
cytoplasmCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5A, mitochondrialHomo sapiens (human)
cytosolCarbonic anhydrase 7Homo sapiens (human)
cytoplasmCarbonic anhydrase 7Homo sapiens (human)
Golgi membrane4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
extracellular region4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
Golgi apparatus4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
Golgi cisterna membrane4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
extracellular exosome4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
methylosome4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
Golgi membraneAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
Golgi apparatusAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
trans-Golgi networkAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
membraneAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
Golgi cisterna membraneAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
Golgi membraneCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
membraneCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
trans-Golgi network membraneCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
extracellular exosomeCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
Golgi medial cisterna membraneCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
Golgi trans cisterna membraneCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
membraneCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 14Homo sapiens (human)
membraneCarbonic anhydrase 14Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 14Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 14Homo sapiens (human)
plasma membraneCarbonic anhydrase 14Homo sapiens (human)
mitochondrionCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
mitochondrial matrixCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
mitochondrionCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
cytoplasmCarbonic anhydrase 5B, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (59)

Assay IDTitleYearJournalArticle
AID1083156Antifungal activity against Diplodia seriata LAT28 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1698174Inhibition of anti-human CD3/CD28/mAbs-stimulated human T-cell proliferation at 30 uM after 72 hrs by CFSE staining based flow cytometric analysis
AID1368908Cytotoxicity against human A2780 cells assessed as reduction in cell viability at 5 to 100 uM incubated for 24 hrs by MTT assay2018Bioorganic & medicinal chemistry letters, 01-15, Volume: 28, Issue:2
(-)-9'-O-(α-l-Rhamnopyranosyl)lyoniresinol from Lespedeza cuneata suppresses ovarian cancer cell proliferation through induction of apoptosis.
AID1059449Inhibition of mushroom tyrosinase using L-tyrosine as substrate at 100 uM preincubated for 10 mins followed by enzyme addition measured after 20 mins by microplate reader analysis relative to control2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Synthesis, antioxidant capacity, and structure-activity relationships of tri-O-methylnorbergenin analogues on tyrosinase inhibition.
AID269889DPPH radical scavenging activity in ethanol solution2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
Proton dissociation is important to understanding structure-activity relationships of gallic acid antioxidants.
AID462271Inhibition of human CA2 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID357622Antiplatelet activity against washed rabbit platelet assessed as inhibition of collagen-induced platelet aggregation at 100 ug/mL pre-incubated 3 mins before collagen challenge by turbidimetric method2001Journal of natural products, Sep, Volume: 64, Issue:9
Quinoline alkaloids and other constituents of Melicope semecarpifolia with antiplatelet aggregation activity.
AID462280Inhibition of mouse CA13 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID490423Cytoprotective activity against 4HNE-induced cytotoxicity in HMEC1 cells at 25 uM by MTT assay2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Synthesis and antioxidant activity evaluation of a syringic hydrazones family.
AID647625Antioxidant activity assessed as trolox equivalent of ABTS radical scavenging activity relative to control2012European journal of medicinal chemistry, Apr, Volume: 50New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers.
AID269890DPPH radical scavenging activity in liposome2006Bioorganic & medicinal chemistry letters, Aug-01, Volume: 16, Issue:15
Proton dissociation is important to understanding structure-activity relationships of gallic acid antioxidants.
AID1891161Inhibition of alpha-glycosidase (unknown origin) using pre-mix of compound and enzyme for 10 mins and then followed by maltose substrate addition and further incubated for 10 mins by microplate reader analysis2022Bioorganic & medicinal chemistry letters, 06-01, Volume: 65Polyphenolic compounds: Synthesis, assessment of antimicrobial effect and enzymes inhibition against important medicinal enzymes with computational details.
AID462272Inhibition of human CA3 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1433347Antineuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID1433348Cytotoxicity against human BT549 cells after 48 hrs by SRB assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID462275Inhibition of human CA5B by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1424230Electrochemical behaviour of the compound assessed as peak potential using disposable screen-printed carbon electrodes2017European journal of medicinal chemistry, Jun-16, Volume: 133Free radicals and polyphenols: The redox chemistry of neurodegenerative diseases.
AID1881860Inhibition of PKM2 (unknown origin)2022Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
AID1083162Antifungal activity against Neofusicoccum parvum Bp0014 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID462274Inhibition of human CA5A by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID357617Antiplatelet activity against washed rabbit platelet assessed as inhibition of arachidonic acid-induced platelet aggregation at 100 ug/mL pre-incubated 3 mins before arachidonic acid challenge by turbidimetric method2001Journal of natural products, Sep, Volume: 64, Issue:9
Quinoline alkaloids and other constituents of Melicope semecarpifolia with antiplatelet aggregation activity.
AID278000Antitubercular activity against Mycobacterium tuberculosis 90-2213872007Journal of natural products, Feb, Volume: 70, Issue:2
Antitubercular dihydroagarofuranoid sesquiterpenes from the roots of Microtropis fokienensis.
AID1433350Cytotoxicity against human SKOV3 cells after 48 hrs by SRB assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID462281Inhibition of human CA14 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID357614Antiplatelet activity against washed rabbit platelet assessed as inhibition of thrombin-induced platelet aggregation at 100 ug/mL pre-incubated 3 mins before thrombin challenge by turbidimetric method2001Journal of natural products, Sep, Volume: 64, Issue:9
Quinoline alkaloids and other constituents of Melicope semecarpifolia with antiplatelet aggregation activity.
AID1083157Antifungal activity against Lasiodiplodia theobromae CBS116460 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1891162Inhibition of alpha-glycosidase (unknown origin) using pre-mix of compound and maltose substrate for 10 mins and then followed by enzyme addition and further incubated for 10 mins by microplate reader analysis2022Bioorganic & medicinal chemistry letters, 06-01, Volume: 65Polyphenolic compounds: Synthesis, assessment of antimicrobial effect and enzymes inhibition against important medicinal enzymes with computational details.
AID336952Inhibition of bovine thymocytes protein tyrosine kinase assessed as angiotensin 1 phosphorylation
AID1083154Antifungal activity against Diplodia seriata BoF98-1 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID462273Inhibition of human CA4 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1433351Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID1083171Antifungal activity against Togninia minima SO21 assessed as susceptibility at 500 uM measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1083163Antifungal activity against Botryosphaeria dothidea OGE14 assessed as growth inhibition measured after 1 to 10 days relative to control2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID462277Inhibition of human CA7 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1059454Antioxidant activity assessed as trolox equivalent of APPH-induced peroxyl radical scavenging activity at 5 to 20 uM measured every 1 min for 120 mins by ORAC fluorescence assay2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Synthesis, antioxidant capacity, and structure-activity relationships of tri-O-methylnorbergenin analogues on tyrosinase inhibition.
AID462278Inhibition of human CA9 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1083159Antifungal activity against Diplodia mutila BRA08 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1083161Antifungal activity against Neofusicoccum parvum PER20 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID388743Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Inhibition of aldose reductase from cataracted eye lenses by finger millet (Eleusine coracana) polyphenols.
AID1433346Cytotoxicity against rat C6 cells assessed as cell viability at 20 uM by MTT assay relative to control2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID1083158Antifungal activity against Diplodia seriata PLU03 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID357625Antiplatelet activity against washed rabbit platelet assessed as inhibition of platelet activating factor-induced platelet aggregation at 100 ug/mL pre-incubated 3 mins before PAF challenge by turbidimetric method2001Journal of natural products, Sep, Volume: 64, Issue:9
Quinoline alkaloids and other constituents of Melicope semecarpifolia with antiplatelet aggregation activity.
AID383183Inhibition of Saccharomyces sp. alpha-glucosidase2008Journal of natural products, May, Volume: 71, Issue:5
alpha-Glucosidase inhibitory activity of triterpenoids from Cichorium intybus.
AID1433349Cytotoxicity against human A549 cells after 48 hrs by SRB assay2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID462279Inhibition of human CA12 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID388742Inhibition of cataracted human eye lens aldose reductase2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Inhibition of aldose reductase from cataracted eye lenses by finger millet (Eleusine coracana) polyphenols.
AID1083160Antifungal activity against Neofusicoccum luteum CBS110299 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1090826Antifeedant activity against Hylobius abietis (pine weevil ) in compound pre-treated Scots pine twig at 50 mM measured after 24 hr by two-choice laboratory bioassay2007Journal of agricultural and food chemistry, Nov-14, Volume: 55, Issue:23
Quantitative structure-activity relationships of pine weevil antifeedants, a multivariate approach.
AID1424231Antioxidant activity assessed as DPPH free radical scavenging activity2017European journal of medicinal chemistry, Jun-16, Volume: 133Free radicals and polyphenols: The redox chemistry of neurodegenerative diseases.
AID1433345Induction of nerve growth factor secretion in rat C6 cells at 20 uM after 24 hrs by ELISA relative to control2016Journal of natural products, 10-28, Volume: 79, Issue:10
Wasabisides A-E, Lignan Glycosides from the Roots of Wasabia japonica.
AID1059453Inhibition of mushroom tyrosinase using L-tyrosine as substrate preincubated for 10 mins followed by enzyme addition measured after 20 mins by microplate reader analysis2013Bioorganic & medicinal chemistry letters, Dec-15, Volume: 23, Issue:24
Synthesis, antioxidant capacity, and structure-activity relationships of tri-O-methylnorbergenin analogues on tyrosinase inhibition.
AID1070421Inhibition of NF-kappaB activity in TNF-alpha stimulated human HEK-293/NF-kB-luc cells incubated for 30 mins prior to TNF-alpha challenge for 4 hrs by luciferase reporter gene assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
NF-κB inhibitors from Eurycoma longifolia.
AID1239713Anti-platelet activity in rat platelet rich plasma assessed as inhibition of ADP and calcium-induced platelet aggregation at 100 uM pre-incubated at 37 degC for 10 mins and measured 30 mins after ADP and calcium addition2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Potential therapeutic agents for circulatory diseases from Bauhinia glauca Benth.subsp. pernervosa. (Da Ye Guan Men).
AID462270Inhibition of human CA1 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1083155Antifungal activity against Diplodia seriata BoF99-1 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID462276Inhibition of human CA6 by stopped-flow CO2 hydration assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.
AID1799599Esterase Activity Assay from Article 10.1111/j.1747-0285.2010.00965.x: \\Carbonic anhydrase inhibitors: Inhibition of human erythrocyte isozymes I and II with a series of phenolic acids.\\2010Chemical biology & drug design, May, Volume: 75, Issue:5
Carbonic anhydrase inhibitors: Inhibition of human erythrocyte isozymes I and II with a series of phenolic acids.
AID1799773SPA Assay from Article 10.1016/j.abb.2004.02.039: \\Inhibition of fucosyltransferase VII by gallic acid and its derivatives.\\2004Archives of biochemistry and biophysics, May-01, Volume: 425, Issue:1
Inhibition of fucosyltransferase VII by gallic acid and its derivatives.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (283)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (3.53)18.7374
1990's17 (6.01)18.2507
2000's49 (17.31)29.6817
2010's128 (45.23)24.3611
2020's79 (27.92)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 49.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index49.30 (24.57)
Research Supply Index5.68 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index77.29 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (49.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.69%)5.53%
Reviews4 (1.37%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other285 (97.94%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]